Portage Biotech
PRTG
#10207
Rank
C$21.2 M
Marketcap
Country
C$9.30
Share price
-2.16%
Change (1 day)
25.68%
Change (1 year)

Earnings for Portage Biotech (PRTG)

Earnings in 2024 (TTM): -C$0.11 Billion

According to Portage Biotech's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -C$0.24 Billion a decrease over its 2022 earnings that were of -C$23.32 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Portage Biotech from 2001 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.11 Billion-54.78%
2023 -C$0.24 Billion891.76%
2022 -C$23.32 Million-18.44%
2021 -C$28.59 Million348.58%
2020 -C$6.38 Million-39.96%
2019 -C$10.62 Million-106.26%
2018 C$0.16 B-621.51%
2017 -C$32.53 Million-213.76%
2016 C$28.59 M-336.72%
2015 -C$12.08 Million81.72%
2014 -C$6.65 Million-4.91%
2013 -C$6.99 Million
2007 -C$0.02 Million-101.23%
2006 C$1.25 M-116.89%
2005 -C$7.43 Million264.28%
2004 -C$2.04 Million650.8%
2003 -C$0.28 Million-54.15%
2002 -C$0.6 Million11.37%
2001 -C$0.54 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NRC Health
NRC
C$37.67 M-135.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
-C$2.96 Million-97.24% Bahamas